<?xml version="1.0" encoding="UTF-8"?>
<ref id="B127-vaccines-07-00179">
 <label>127.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gaspar</surname>
    <given-names>L.P.</given-names>
   </name>
   <name>
    <surname>Mendes</surname>
    <given-names>Y.S.</given-names>
   </name>
   <name>
    <surname>Yamamura</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>Almeida</surname>
    <given-names>L.F.</given-names>
   </name>
   <name>
    <surname>Caride</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Goncalves</surname>
    <given-names>R.B.</given-names>
   </name>
   <name>
    <surname>Silva</surname>
    <given-names>J.L.</given-names>
   </name>
   <name>
    <surname>Oliveira</surname>
    <given-names>A.C.</given-names>
   </name>
   <name>
    <surname>Galler</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Freire</surname>
    <given-names>M.S.</given-names>
   </name>
  </person-group>
  <article-title>Pressure-inactivated yellow fever 17DD virus: Implications for vaccine development</article-title>
  <source>J. Virol. Methods</source>
  <year>2008</year>
  <volume>150</volume>
  <fpage>57</fpage>
  <lpage>62</lpage>
  <pub-id pub-id-type="doi">10.1016/j.jviromet.2008.03.002</pub-id>
  <pub-id pub-id-type="pmid">18420285</pub-id>
 </element-citation>
</ref>
